cause circle brand logo
cause circle brand logo
    MANAGE
    Profile
    User Name
    Role
    PROFILE
    View Profile
    SETTINGS
    Edit Profile
    STAGE ENVIRONMENT
    Stage Environment
    MANAGE
    Logout
    Sign In
    Profile
    User Name
    Role
    PROFILE
    View Profile
    CONTENT
    Content Events
    SETTINGS
    Edit Profile Privacy & Security Notification Settings Connected Accounts
    MANAGE
    SUPPORT
    Guide Help Center
    Donation collected 11 Donations
    US,366,460 Collected
    Logout
    • Home
    • Stories
    • About CauseCircle
    • Blog
    • How It Works
    • Nonprofit Directory
    • Claim Listing
    • Why CauseCircle?
    • For Corporations
    • Feedback
    • Contact Us
    • Home
    • Stories
    • About
      • About CauseCircle
      • Blog
    • Nonprofits
      • How It Works
      • Nonprofit Directory
      • Claim Listing
    • Why CauseCircle?
    • For Corporations
    • Feedback
    • Contact Us
    Send Feedback

    Help us improve CauseCircle

    We value your feedback! Please let us know if you've encountered any issues, bugs, or if you have suggestions for improving our platform.

    Thank You!

    Thank you for your feedback!

    Your feedback helps us:

    • Fix issues and improve platform stability
    • Develop new features based on user suggestions
    • Make CauseCircle better for everyone
    Follow a Nonprofit First

    To create posts, you need to follow at least one nonprofit. Find nonprofits that align with your values and start following them!

    Follow This Nonprofit First

    To post about this nonprofit, you need to follow them first! Click the follow button on this page to get started.

    cause circle brand logo
    1 Story Information
    2 Share
    Step icon

    Please select an NPO.

    Choose images or videos, or drag & drop them here.

    JPEG, PNG, MP4 and other formats, up to 30 MB each. Maximum 5 media files allowed.

    Please enter a story description.
    Please select a category (optional).
    Step icon

    Share Link

    Spread the word on your favorite platforms.

    Organization
    posted by

    Story Statistics

    2,345 Reads

    80 Shares

    320 Likes

    Related Stories

    1 year ago

    Navigating the school year with type 1 diabetes: A call to support and action

    Editor’s note: Written by guest blogger Matthew Tilton, D.O. In addition to being a physician, he is the father of  9-year-old Adalyn (pictured above), who lives with type 1 diabetes (T1D). Read his previous story for Breakthrough T1D.

    As summer draws to a close and the back-to-school season begins, many parents are busy preparing their children for a new academic year. For many families, this requires a few more checkboxes on the list. My daughter Adalyn, who has type 1 diabetes (T1D), requires more than the usual school supplies and new clothes. Our back-to-school checklist includes items like insulin, glucose monitors, and an emergency care plan, all essential for her well-being.

    As a parent of a child with T1D, the transition to a new school year brings a mix of emotions. There’s the usual excitement and straight-up anxiety. Will the teachers have questions? What will her classmates say? These are the questions that linger in my mind as the school year approaches. It turns out I am more anxious than she is.

    The importance of a well-coordinated support system

    Adalyn, however, is determined to approach the new school year with confidence. “I am a little nervous, but not much. I know my nurse is there to help me,” she said recently. Her words are a reminder of the importance of having a well-coordinated support system in place. Making sure the school nurse knows Adalyn’s care plan and is prepared to respond to any situation is a critical step in ensuring her safety.

    Related content: School nurses have incredible impact

    Additionally, we’ve worked closely with her teachers to make sure they’re aware of her condition and know how to take the right steps now to ensure her success later. This includes understanding the signs of high or low blood sugar and knowing when to allow her a break or snack. If you are looking for permission to be “that parent,” here you go. Be that parent. As a physician, occasional coach, and father, I have never once thought, “Oh, I really regret being too prepared for this.” I am sure I may be a headache, but it is this collaboration between parents, healthcare professionals, and educators that forms the foundation of a safe and supportive learning environment.

    Creating an environment for thriving

    Let’s not forget that continuous glucose monitors and insulin pumps have been life-changing. I’m thankful for the incredible advancements in medical technology that allow Adalyn to lead a relatively normal life. These tools enable her to do things she loves, like playing softball and other sports. But these tools are only part of the equation. The real challenge lies in creating an environment where she can thrive academically and socially, without constant worry. 

    This is where awareness and education become crucial. Schools must be equipped with the knowledge to support students with T1D, with the necessary medical supplies, and foster an environment where every child feels safe and understood. I have it on good authority teachers aren’t trained on T1D and all that comes along with it. That is where we—the prepared parents—come in. Teachers, staff, and even fellow students need to understand what T1D is and how they can help. A simple understanding can go a long way in making sure children like Adalyn feel safe and supported.

    Setting our schools—and kids—up for success

    If there’s one thing I’ve learned, it’s that managing type 1 diabetes is a team effort. It requires not just the dedication of parents and medical professionals, but also the understanding and cooperation of educators and community members.

    So, as we prepare for another school year, I want to make a call to action. Let’s set our schools—and our kids—up for success. Let’s ensure that our schools are prepared to support children with T1D and other chronic conditions. This means advocating for better training for school staff, ensuring that schools have the necessary medical supplies, and fostering an environment where every child feels safe and understood.

    As we send our children back to school, let’s also commit to sending them into environments where their health needs are met with compassion and competence. Let’s work together to ensure that every child, regardless of their medical condition, has the opportunity to learn and grow in a safe and supportive setting. This is not just about managing a disease; it’s about empowering our children to live their fullest lives. And until there are cures, we parents and caregivers must be the advocates, the educators, and the support system they need.

    Together, we can make a difference

    Breakthrough T1D offers a school guide to help parents advocate for their children’s needs. They also have resources to help educators understand the unique needs of students with T1D. Consult their T1D Resource Library for the school guide and other helpful life with T1D guides. 

    The road ahead is challenging, but we are not alone. Together, we can make a difference. Just like Adalyn confidently steps up to every challenge, we, too, must step up, ensuring that every child with T1D has the chance to thrive, both in school and in life.

    1 year ago

    Breakthrough T1D Spearheads the Formation of Monitoring Guidelines

    You have heard Breakthrough T1D say it before: Build a global universal type 1 diabetes (T1D) early detection program. This will reduce diabetes ketoacidosis (DKA)—a life-threatening complication—at diagnosis and identify autoantibody-positive individuals to take part in preventive treatment or clinical trials. 


    Having 2 or more persistent T1D autoantibodies—antibodies that are directed toward your own body—means you have an almost 100 percent chance of developing T1D in your lifetime. 


    But there have been no monitoring guidelines for individuals who tested positive for T1D autoantibodies through early detection. Until now.

    Consensus Guidance

    Breakthrough T1D spearheaded an effort to develop the first internationally agreed-upon guidance for anyone who tests positive for T1D autoantibodies, co-published today in the journals Diabetes Care and Diabetologia.  

    These provide guidelines for monitoring children, adolescents, and adults who test positive for T1D autoantibodies, along with recommended monitoring frequencies and actions for healthcare professionals when the risk of progression toward symptomatic T1D is high.  

    The guidance also includes recommendations for educational and psychosocial support for positive T1D antibody individuals, including their families and caregivers, and may also lead to primary care doctors screening more frequently since there is actionable monitoring guidance available to them.   

    For the first time, individuals, families, and healthcare professionals have concrete next steps to monitor early stage T1D progression and catch symptoms early to prevent DKA.   


    This guidance was developed in conjunction with over 60 international experts, representing 10 countries and endorsed by 11 national and international societies. 

    1 year ago

    ADA Takeaways: Day 2

    The American Diabetes Association’s 84th Scientific Sessions is here! Scientists will present the latest type 1 diabetes (T1D) research, from early detection to glucose control to complications, all with the goal of improving lives for the T1D community.

    1. In November 2022, the FDA approved Tzield™ (teplizumab-mzwv) for use in delaying the onset of clinical T1D. With the availability of a treatment option for people with Stage 2 T1D, the field has changed its outlook on delay and prevention and navigating pediatric T1D, especially in the early stages. Annette-Gabriele Ziegler, M.D., presented on several screening programs in Europe, including Fr1da, which has screened 200,000+ pediatric participants and found that it significantly reduces DKA onset at clinical diagnosis, and GPPAD, which identifies infants with an elevated genetic risk of developing T1D and enrolls them in primary prevention clinical trials. Andrea Steck, M.D., highlighted the value of CGM-based metrics in evaluating T1D risk and R. Brett McQueen, Ph.D., discussed the economics of early detection.

    At-risk, or Stage 2 T1D, means that a person exhibited 2+ T1D-related autoantibodies—antibodies against one’s own self—and their blood glucose is starting to be abnormal, but they are not yet insulin dependent. When someone becomes insulin-dependent, they are in stage 3 T1D.


    • We got updates on several automated insulin delivery (AID), or artificial pancreas, systems, including the:
      • Medtronic MiniMed 780G, especially the importance of initiating it as soon as possible following diagnosis (which is now recommended in the ADA Standards of Care for both children and adults), citing the CLVer trial, which found clinically meaningful and sustained improvements in blood sugar management following early AID initiation.
      • Medtronic MiniMed 780G in high-risk youth with T1D, with 80 participants aged 7-25 years, who demonstrated an average HbA1c reduction of 2.5% (from an average baseline HbA1c of 10.5% to 8%), improvement in time-in-range, and a reduction in low blood sugar events.
      • Tandem Mobi among early pediatric and adult adopters.
      • Sequel Med Tech’s twist AID system, which was FDA-cleared for people with T1D aged 2+ in March 2024. The system uses the DEKA Loop algorithm, which is based on the FDA cleared Tidepool Loop (iAGC) and is intended for use with compatible interoperable continuous glucose monitors (iCGMs). Sequel is Tidepool’s first publicly announced insulin delivery device partner with an FDA-cleared system that will integrate Tidepool Loop.
    • In therapy, the full INHALE-3 results demonstrated the non-inferiority of inhaled insulin (Afrezza) used with insulin degludec compared to usual care. Baseline HbA1c was 7.6% across groups, and, on average, HbA1c in both groups remained stable from baseline to 17 weeks. Overall, 30% of the inhaled insulin group reached <7.0% A1c at 17 weeks compared to only 17% of the usual care group.
    Report Story

    Why are you reporting this Story?

    Your report is anonymous, except if you're reporting an intellectual property infringement. If someone is in immediate danger, call the local emergency services - don't wait.

    Report Story

    Any Additional Notes

    Your report is anonymous, except if you're reporting an intellectual property infringement. If someone is in immediate danger, call the local emergency services - don't wait.

    Report Story

    Thanks for letting us know

    We use these reports to:

    • Understand problems that people are having with different types of content on CauseCircle
    • Show you less of this kind of content in the future
    Share this story
    twitter-logo
    Twitter
    facebook-logo
    Facebook
    linkedin-logo
    LinkedIn
    whatsapp-logo
    WhatsApp
    reddit-logo
    Reddit
    telegram-logo
    Telegram
    pinterest-logo
    Pinterest
    email-logo
    Email
    Page link

    Please Sign In to continue

    Edit Story
    cause circle brand logo

    CauseCircle is a modern content collection hub for nonprofits. Collect all forms of powerful content - photos, videos, testimonials, reviews and field stories from your staff, volunteers, and supporters —  in one secure hub your nonprofit fully owns and controls.

    Turn everyday moments into proof of impact you can use across campaigns, grants, and fundraising to build transparency, trust, and donor confidence.

    Explore
    • About CauseCircle
    • FAQs
    • Nonprofit Directory
    • CauseCircle CMS
    • About the Product
    • Partners
    • Help Center
    Contact
    • Email: hello@causecircle.org
    • Contact Us

    Copyright© 2025, All rights reserved.

    Terms of Service Privacy Policy